05:44 PM EDT, 05/06/2025 (MT Newswires) -- Cytokinetics ( CYTK ) reported a Q1 net loss late Tuesday of $1.36 per diluted share, widening from the loss of $1.33 a year earlier.
Analysts polled by FactSet expected a loss of $1.38.
Revenue in the three months ended March 31 rose to $1.6 million from $835,000 a year earlier.
Analysts surveyed by FactSet expected $2.5 million.